Nothing Without Us: Civil Society Solutions to the COVID-19 Pandemic


Simon Collins
HIV i-Base
Winifred Ikilai
National Forum of People Living with HIV & AIDS Networks
Rob Newells
Black AIDS Institute
Midnight Poonkasetwattana
Asia Pacific Coalition on Male Sexual Health
Shobha Shukla
Citizen News Service


Jim Pickett
AIDS Foundation Chicago

June 22, 2021

7:00 AM - 8:15 AM PT (8:00 AM - 9:15 AM MT; 9:00 AM - 10:15 AM CT; 10:00 AM ET - 11:15 AM ET)  


Assessment of Needs

The COVID-19 pandemic has created an unprecedented disruption in life as we know it, affecting not only the public health of communities worldwide but our economic and social wellbeing.

Similar to some 40 years ago, the global HIV community of advocates and activists are leading the charge in the grassroots community response against this devastating new pandemic. Our accumulated experience and skills will be the key to finding solutions and providing support to those who are the most overlooked and affected among us.

The COVID Advocates Advisory Board is a group of civil society organizations and global health advocates committed to bringing communities together and, by gleaning insight from HIV activism, setting the path toward resolving the inequities that COVID-19 has exacerbated.

This session brings together the experience of fierce  HIV and COVID-19 advocates from grassroots organizations around the globe with shared and vital goals of learning from one another, defining best practices, valuing the role of communities, and demanding accountability in the fight for equity in the global COVID-19 response. We invite you to join us for a robust, interactive discussion on these topics.

Learning Objectives

On completion of this webinar, learners will be able to:

  • Identify strategies and initiatives being done globally by community advocates and members to address the COVID-19 pandemic
  • Describe the interactions and parallels in HIV and COVID-19 advocacy


Who Should Attend

This webinar is designed for clinical decision makers and community members who are actively involved in HIV and COVID-19 care, research, and advocacy.

This activity is also relevant for nursing professionals, physician assistants, pharmacists, and other health care professionals.

Individual registration is required, even if you are viewing as a group, in order to receive CME credit or a certificate of participation.

Registration closes on Tuesday, June 22, 2021, 6:00 AM (PT).

Certificates will be available after the completion of the evaluation and claim form.

For more information or questions, please contact the registration department at or 415-544-9400.

Conflicts of Interest

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Grant Support

This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.


Gilead Sciences, Inc.
Merck & Co., Inc.
ViiV Healthcare


Janssen Therapeutics


Theratechnologies Inc.

Frequently Asked Questions

View our list of FAQs about attending a webinar.

Further Questions?
Please contact the registration department at or 415-544-9400.